Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Condition: Breast Cancer Interventions: Drug: Trastuzumab deruxtecan; Drug: Docetaxel; Drug: Paclitaxel; Drug: Carboplatin; Drug: Trastuzumab; Drug: Pertuzumab; Drug: Ribociclib; Drug: Letrozole; Drug: Epirubicin; Drug: Cyclophosphamide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials